Cargando…
Safety of COVID-19 vaccination in patients with polyethylene glycol allergy: A case series
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma & Immunology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685412/ https://www.ncbi.nlm.nih.gov/pubmed/34949564 http://dx.doi.org/10.1016/j.jaip.2021.11.021 |
_version_ | 1784617829893406720 |
---|---|
author | Picard, Matthieu Drolet, Jean-Philippe Masse, Marie-Soleil Filion, Charles A. ALMuhizi, Faisal Fein, Michael Copaescu, Ana Isabwe, Ghislaine Annie C. Blaquière, Martin Primeau, Marie-Noël |
author_facet | Picard, Matthieu Drolet, Jean-Philippe Masse, Marie-Soleil Filion, Charles A. ALMuhizi, Faisal Fein, Michael Copaescu, Ana Isabwe, Ghislaine Annie C. Blaquière, Martin Primeau, Marie-Noël |
author_sort | Picard, Matthieu |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8685412 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Academy of Allergy, Asthma & Immunology |
record_format | MEDLINE/PubMed |
spelling | pubmed-86854122021-12-20 Safety of COVID-19 vaccination in patients with polyethylene glycol allergy: A case series Picard, Matthieu Drolet, Jean-Philippe Masse, Marie-Soleil Filion, Charles A. ALMuhizi, Faisal Fein, Michael Copaescu, Ana Isabwe, Ghislaine Annie C. Blaquière, Martin Primeau, Marie-Noël J Allergy Clin Immunol Pract Clinical Communications American Academy of Allergy, Asthma & Immunology 2022-02 2021-12-20 /pmc/articles/PMC8685412/ /pubmed/34949564 http://dx.doi.org/10.1016/j.jaip.2021.11.021 Text en © 2021 American Academy of Allergy, Asthma & Immunology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Clinical Communications Picard, Matthieu Drolet, Jean-Philippe Masse, Marie-Soleil Filion, Charles A. ALMuhizi, Faisal Fein, Michael Copaescu, Ana Isabwe, Ghislaine Annie C. Blaquière, Martin Primeau, Marie-Noël Safety of COVID-19 vaccination in patients with polyethylene glycol allergy: A case series |
title | Safety of COVID-19 vaccination in patients with polyethylene glycol allergy: A case series |
title_full | Safety of COVID-19 vaccination in patients with polyethylene glycol allergy: A case series |
title_fullStr | Safety of COVID-19 vaccination in patients with polyethylene glycol allergy: A case series |
title_full_unstemmed | Safety of COVID-19 vaccination in patients with polyethylene glycol allergy: A case series |
title_short | Safety of COVID-19 vaccination in patients with polyethylene glycol allergy: A case series |
title_sort | safety of covid-19 vaccination in patients with polyethylene glycol allergy: a case series |
topic | Clinical Communications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685412/ https://www.ncbi.nlm.nih.gov/pubmed/34949564 http://dx.doi.org/10.1016/j.jaip.2021.11.021 |
work_keys_str_mv | AT picardmatthieu safetyofcovid19vaccinationinpatientswithpolyethyleneglycolallergyacaseseries AT droletjeanphilippe safetyofcovid19vaccinationinpatientswithpolyethyleneglycolallergyacaseseries AT massemariesoleil safetyofcovid19vaccinationinpatientswithpolyethyleneglycolallergyacaseseries AT filioncharlesa safetyofcovid19vaccinationinpatientswithpolyethyleneglycolallergyacaseseries AT almuhizifaisal safetyofcovid19vaccinationinpatientswithpolyethyleneglycolallergyacaseseries AT feinmichael safetyofcovid19vaccinationinpatientswithpolyethyleneglycolallergyacaseseries AT copaescuana safetyofcovid19vaccinationinpatientswithpolyethyleneglycolallergyacaseseries AT isabweghislaineanniec safetyofcovid19vaccinationinpatientswithpolyethyleneglycolallergyacaseseries AT blaquieremartin safetyofcovid19vaccinationinpatientswithpolyethyleneglycolallergyacaseseries AT primeaumarienoel safetyofcovid19vaccinationinpatientswithpolyethyleneglycolallergyacaseseries |